Killer Cell Activating Receptor–Associated Protein Exacerbates Intestinal Inflammation Through Promoting Kynurenine–Aryl Hydrocarbon Receptor–Dependent Neutrophil Activation in Ulcerative Colitis
Year: 2026
Type: article
Abstract: BACKGROUND & AIMS: Killer cell activating receptor-associated protein, also known as TYRO protein tyrosine kinase binding protein, has been reported to participate in the regulation of autoimmunity and inflammation. However, the underlying mechanisms involved in intestinal mucosal inflammation in ulcerative colitis remain obscure. METHODS: We analyzed killer cell activating receptor-associated protein expression in colon tissues from patients with ulcerative colitis and established dextran sulfate sodium-induced colitis models in killer cell activating receptor-associated protein knockout mice to determine the potential role of killer cell activating receptor-associated protein in the induction of mucosal inflammation. To clarify the immunoregulation of neutrophils on intestinal epithelial barrier function, we cocultured neutrophils isolated from killer cell activating receptor-associated protein knockout or wild-type mice with intestinal epithelial cells. Additionally, we profiled neutrophil tryptophan metabolites using targeted metabolomics. RESULTS: Our data demonstrated that killer cell activating receptor-associated protein was highly expressed in the intestinal mucosal tissue and peripheral blood neutrophils of patients with active ulcerative colitis, particularly in neutrophils. Inhibition of killer cell activating receptor-associated protein promoted anti-inflammatory immune responses in neutrophils in vitro, showing a significant decrease in the expression of proinflammatory cytokines, including interleukin6, tumor necrosis factor-α, and interleukin1β. Consistently, killer cell activating receptor-associated protein deficiency alleviated dextran sulfate sodium-induced colitis in mice and improved intestinal mucosal barrier integrity via the aryl hydrocarbon receptor-interleukin22 pathway in neutrophils. Mechanistically, killer cell activating receptor-associated protein deficiency enhanced the nuclear translocation of aryl hydrocarbon receptor through the indoleamine 2,3-dioxygenase 1-kynurenine pathway in neutrophils. Notably, administration of killer cell activating receptor-associated protein knockout neutrophils alleviated mucosal inflammation in dextran sulfate sodium-induced colitis mice. CONCLUSIONS: Overall, our study highlights the critical role of killer cell activating receptor-associated protein in mucosal inflammation in ulcerative colitis by promoting neutrophil proinflammatory immune responses and disrupting the intestinal mucosal barrier integrity, suggesting that targeting killer cell activating receptor-associated protein in neutrophils may represent a novel therapeutic approach for ulcerative colitis.
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,430
OpenAlex ID: W7214241964
